搜尋結果
Pfizer's Duchenne gene therapy fails in late-stage study
Reuters· 6 日前, opens new tab said on Wednesday its experimental gene therapy for Duchenne muscular dystrophy ...
Will Pfizer Stock Rebound To Its 2021 Highs Of $60?
Forbes· 1 日前Pfizer stock (NYSE: PFE) currently trades at $28 per share, 55% below its peak level of $61 seen in December 2021. PFE stock ...
Health Care Roundup: Market Talk
The Wall Street Journal· 5 日前Find insight on Pfizer, Mankind Pharma and more in the latest Market Talks covering the Health ...